Cancer Trials Database Comment Window Gets 30-Day Boost
Published Date: 3/10/2026
Notice
Summary
The National Cancer Institute is asking for 30 more days of public comments on their Clinical Trials Reporting Program (CTRP) database, which helps track cancer research studies. This correction fixes a previous notice and explains that no comments were received during the first 60 days. The program saves time by reducing duplicate reports, and there’s no cost except the time spent by researchers updating the database.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 2 costs, 0 mixed.
Annual Time Burden on Researchers
Clinical research administrators and other respondents are estimated to spend a total of 18,000 hours per year on the CTRP database. The notice lists 9,000 respondents, 24,000 annual responses, and 18,000 estimated annualized burden hours.
Per-Report Time and Frequency Requirements
The CTRP requires initial trial registration that takes 1 hour, trial registration updates that take 1 hour, trial registration amendments that take 1 hour, and accrual updates that take 30 minutes each. The notice states there are three amendments and four accrual updates per trial each year.
No Monetary Costs; Fewer Duplicate Reports
The notice says there are no costs to respondents other than their time and that the CTRP consolidates reporting to reduce redundant submissions. OMB approval is requested for three years under control number 0925-0600.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06501 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a cool new invention—special human antibodies that can fight certain cancers and autoimmune diseases—for companies to license and develop into treatments. This means businesses can jump on this opportunity to create powerful new medicines using government-backed research. Interested parties should act soon and may need to sign agreements to get full details.
2026-06283 — Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration
The National Eye Institute plans to give Perpetual Biosciences, Inc. an exclusive license to use special PEDF peptides to treat eye diseases that cause vision loss. This means the company will have the sole right to develop and sell this promising treatment, potentially helping millions with retinal degeneration. If you want to comment or apply for a license, act fast—submissions close April 16, 2026!
2026-05957 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in April 2026 to review and decide on important research grant applications. These meetings affect scientists seeking funding in areas like neuroscience, cancer, and liver disease. No public access is allowed to protect private info and trade secrets, and these reviews help decide where millions in research money will go.
2026-05672 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
The National Institute on Deafness and Other Communication Disorders is holding two closed meetings in late April and early May 2026 to review grant applications and evaluate researchers’ qualifications. These meetings affect scientists seeking funding and help ensure top-notch research gets supported. No public access means privacy is protected, and the process keeps the money flowing to the best projects on time.
2026-05738 — Submission for OMB Review; 30-Day Comment Request; National Institutes of Health (NIH) Loan Repayment Programs, (Office of the Director)
The NIH is asking for a 30-day public comment on extending its Loan Repayment Programs that help doctors and scientists pay off their student loans while they do important health research. This extension keeps the program running smoothly with no big changes, and comments are due by April 23, 2026. If you’re a researcher with student loans, this program could save you money while you help improve health!
2026-05673 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on April 17, 2026, to review and evaluate important grant applications in health and science fields. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
Previous / Next Documents
Previous: 2026-04634 — Sunshine Act Meetings
The Legal Services Corporation is holding three virtual committee meetings on March 16, 18, and 19, 2026, open for public viewing on YouTube. These meetings cover updates on leadership councils, legal service delivery, and operations, with some parts possibly closed for sensitive discussions. No new costs or deadlines are introduced, but the public gets a clearer window into how legal aid is managed and improved.
Next: 2026-04636 — Certification Notice-258; Notice of Filing of Self-Certification of Coal Capability Under the Powerplant and Industrial Fuel Use Act
South Field Energy LLC has told the Department of Energy that their new power plant can use coal if needed, even though it mainly plans to use natural gas. This is required by law to make sure new power plants can switch fuels if necessary. This notice lets everyone know the plant meets the rules before it starts running, with no extra costs or delays expected.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in